APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 2 Receptor Subunit Alpha

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Interleukin 2 Receptor Subunit Alpha Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025182 pages

Choose your research edition.

Industry ResearchInterleukin 2 Receptor Subunit Alpha Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 2 Receptor Subunit Alpha Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Interleukin 2 Receptor Subunit Alpha Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 2 Receptor Subunit Alpha Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 2 Receptor Subunit Alpha Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Interleukin 2 Receptor Subunit Alpha market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Interleukin 2 Receptor Subunit Alpha include AbbVie Inc., Philogen S.p.A., Mabtech Limited, APT Therapeutics, Inc. and Alkermes Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Interleukin 2 Receptor Subunit Alpha market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Interleukin 2 Receptor Subunit Alpha and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Interleukin 2 Receptor Subunit Alpha sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Interleukin 2 Receptor Subunit Alpha market size, projected growth trends, production technologies, key applications, and end-use industries.

Interleukin 2 Receptor Subunit Alpha Segment by Company

AbbVie Inc.

Philogen S.p.A.

Mabtech Limited

APT Therapeutics, Inc.

Alkermes Plc

Interleukin 2 Receptor Subunit Alpha Segment by Type

APT-602

DEL-106

MDNA-209

NKTR-358

Others

Interleukin 2 Receptor Subunit Alpha Segment by Application

Ovarian Cancer

Renal Cell Carcinoma

Blood Cancer

Autoimmune Disorders

Others

Interleukin 2 Receptor Subunit Alpha Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 2 Receptor Subunit Alpha market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 2 Receptor Subunit Alpha and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 2 Receptor Subunit Alpha.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Interleukin 2 Receptor Subunit Alpha market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Interleukin 2 Receptor Subunit Alpha manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Interleukin 2 Receptor Subunit Alpha in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Interleukin 2 Receptor Subunit Alpha in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Interleukin 2 Receptor Subunit Alpha Industry Trends Table 2. Interleukin 2 Receptor Subunit Alpha Industry Drivers Table 3. Interleukin 2 Receptor Subunit Alpha Industry Opportunities and Challenges Table 4. Interleukin 2 Receptor Subunit Alpha Industry Restraints Table 5. Global Interleukin 2 Receptor Subunit Alpha Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Interleukin 2 Receptor Subunit Alpha Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Manufacturers Table 9. Global Interleukin 2 Receptor Subunit Alpha Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Interleukin 2 Receptor Subunit Alpha Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Interleukin 2 Receptor Subunit Alpha Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Interleukin 2 Receptor Subunit Alpha Manufacturers, Product Type & Application Table 13. Global Interleukin 2 Receptor Subunit Alpha Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Interleukin 2 Receptor Subunit Alpha by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of APT-602 Table 17. Major Manufacturers of DEL-106 Table 18. Major Manufacturers of MDNA-209 Table 19. Major Manufacturers of NKTR-358 Table 20. Major Manufacturers of Others Table 21. Global Interleukin 2 Receptor Subunit Alpha Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 23. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2027-2032) & (W Units) Table 24. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Type (2021-2026) Table 25. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Type (2027-2032) Table 26. Global Interleukin 2 Receptor Subunit Alpha Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Interleukin 2 Receptor Subunit Alpha Revenue by Type (2021-2026) & (W Units) Table 28. Global Interleukin 2 Receptor Subunit Alpha Revenue by Type (2027-2032) & (W Units) Table 29. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Type (2021-2026) Table 30. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Ovarian Cancer Table 32. Major Manufacturers of Renal Cell Carcinoma Table 33. Major Manufacturers of Blood Cancer Table 34. Major Manufacturers of Autoimmune Disorders Table 35. Major Manufacturers of Others Table 36. Global Interleukin 2 Receptor Subunit Alpha Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 38. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2027-2032) & (W Units) Table 39. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2021-2026) Table 40. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2027-2032) Table 41. Global Interleukin 2 Receptor Subunit Alpha Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Interleukin 2 Receptor Subunit Alpha Revenue by Application (2021-2026) & (W Units) Table 43. Global Interleukin 2 Receptor Subunit Alpha Revenue by Application (2027-2032) & (W Units) Table 44. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Application (2021-2026) Table 45. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Application (2027-2032) Table 46. Global Interleukin 2 Receptor Subunit Alpha Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2021-2026) & (W Units) Table 48. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Region (2021-2026) Table 49. Global Interleukin 2 Receptor Subunit Alpha Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Interleukin 2 Receptor Subunit Alpha Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 53. North America Interleukin 2 Receptor Subunit Alpha Sales by Country (2027-2032) & (W Units) Table 54. Europe Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 56. Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2027-2032) & (W Units) Table 63. Global Interleukin 2 Receptor Subunit Alpha Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Interleukin 2 Receptor Subunit Alpha Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Interleukin 2 Receptor Subunit Alpha Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Region (2021-2026) Table 67. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Region (2027-2032) Table 68. AbbVie Inc. Company Information Table 69. AbbVie Inc. Business Overview Table 70. AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 72. AbbVie Inc. Recent Development Table 73. Philogen S.p.A. Company Information Table 74. Philogen S.p.A. Business Overview Table 75. Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 77. Philogen S.p.A. Recent Development Table 78. Mabtech Limited Company Information Table 79. Mabtech Limited Business Overview Table 80. Mabtech Limited Interleukin 2 Receptor Subunit Alpha Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mabtech Limited Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 82. Mabtech Limited Recent Development Table 83. APT Therapeutics, Inc. Company Information Table 84. APT Therapeutics, Inc. Business Overview Table 85. APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 87. APT Therapeutics, Inc. Recent Development Table 88. Alkermes Plc Company Information Table 89. Alkermes Plc Business Overview Table 90. Alkermes Plc Interleukin 2 Receptor Subunit Alpha Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Alkermes Plc Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 92. Alkermes Plc Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Interleukin 2 Receptor Subunit Alpha Distributors List Table 96. Interleukin 2 Receptor Subunit Alpha Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Interleukin 2 Receptor Subunit Alpha Product Image Figure 2. Global Interleukin 2 Receptor Subunit Alpha Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 2 Receptor Subunit Alpha Market Size (2021-2032) & (US$ Million) Figure 4. Global Interleukin 2 Receptor Subunit Alpha Sales (2021-2032) & (W Units) Figure 5. Global Interleukin 2 Receptor Subunit Alpha Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Interleukin 2 Receptor Subunit Alpha Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. APT-602 Image Figure 9. DEL-106 Image Figure 10. MDNA-209 Image Figure 11. NKTR-358 Image Figure 12. Others Image Figure 13. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Type (2021-2032) Figure 16. Global Interleukin 2 Receptor Subunit Alpha Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Type (2021-2032) Figure 19. Ovarian Cancer Image Figure 20. Renal Cell Carcinoma Image Figure 21. Blood Cancer Image Figure 22. Autoimmune Disorders Image Figure 23. Others Image Figure 24. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2021-2032) Figure 27. Global Interleukin 2 Receptor Subunit Alpha Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Application (2021-2032) Figure 30. North America Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2032) Figure 32. U.S. Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2032) Figure 37. Germany Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2032) Figure 44. China Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2032) Figure 52. Brazil Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Interleukin 2 Receptor Subunit Alpha Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Interleukin 2 Receptor Subunit Alpha Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032) & (US$ Million) Figure 63. North America Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032) & (US$ Million) Figure 65. Europe Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Interleukin 2 Receptor Subunit Alpha Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Interleukin 2 Receptor Subunit Alpha Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • APT-602
  • DEL-106
  • MDNA-209
  • NKTR-358
  • Others
Applications
  • Ovarian Cancer
  • Renal Cell Carcinoma
  • Blood Cancer
  • Autoimmune Disorders
  • Others
Companies covered
  • AbbVie Inc.
  • Philogen S.p.A.
  • Mabtech Limited
  • APT Therapeutics, Inc.
  • Alkermes Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Interleukin 2 Receptor Subunit Alpha Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Interleukin 2 Receptor Subunit Alpha Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Interleukin 2 Receptor Subunit Alpha Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Interleukin 2 Receptor Subunit Alpha Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Interleukin 2 Receptor Subunit Alpha Market Dynamics
  1. 2.1 Interleukin 2 Receptor Subunit Alpha Industry Trends
  2. 2.2 Interleukin 2 Receptor Subunit Alpha Industry Drivers
  3. 2.3 Interleukin 2 Receptor Subunit Alpha Industry Opportunities and Challenges
  4. 2.4 Interleukin 2 Receptor Subunit Alpha Industry Restraints
3 Interleukin 2 Receptor Subunit Alpha Market by Manufacturers
  1. 3.1 Global Interleukin 2 Receptor Subunit Alpha Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Interleukin 2 Receptor Subunit Alpha Sales by Manufacturers (2021-2026)
  3. 3.3 Global Interleukin 2 Receptor Subunit Alpha Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Interleukin 2 Receptor Subunit Alpha Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Interleukin 2 Receptor Subunit Alpha Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Interleukin 2 Receptor Subunit Alpha Manufacturers, Product Type & Application
  7. 3.7 Global Interleukin 2 Receptor Subunit Alpha Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Interleukin 2 Receptor Subunit Alpha Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Interleukin 2 Receptor Subunit Alpha Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Interleukin 2 Receptor Subunit Alpha Tier 1, Tier 2, and Tier 3
4 Interleukin 2 Receptor Subunit Alpha Market by Type
  1. 4.1 Interleukin 2 Receptor Subunit Alpha Type Introduction
  2. 4.1.1 APT-602
  3. 4.1.2 DEL-106
  4. 4.1.3 MDNA-209
  5. 4.1.4 NKTR-358
  6. 4.1.5 Others
  7. 4.2 Global Interleukin 2 Receptor Subunit Alpha Sales by Type
  8. 4.2.1 Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2032)
  10. 4.2.3 Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Type (2021-2032)
  11. 4.3 Global Interleukin 2 Receptor Subunit Alpha Revenue by Type
  12. 4.3.1 Global Interleukin 2 Receptor Subunit Alpha Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Interleukin 2 Receptor Subunit Alpha Revenue by Type (2021-2032)
  14. 4.3.3 Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Type (2021-2032)
5 Interleukin 2 Receptor Subunit Alpha Market by Application
  1. 5.1 Interleukin 2 Receptor Subunit Alpha Application Introduction
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Renal Cell Carcinoma
  4. 5.1.3 Blood Cancer
  5. 5.1.4 Autoimmune Disorders
  6. 5.1.5 Others
  7. 5.2 Global Interleukin 2 Receptor Subunit Alpha Sales by Application
  8. 5.2.1 Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2032)
  10. 5.2.3 Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2021-2032)
  11. 5.3 Global Interleukin 2 Receptor Subunit Alpha Revenue by Application
  12. 5.3.1 Global Interleukin 2 Receptor Subunit Alpha Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Interleukin 2 Receptor Subunit Alpha Revenue by Application (2021-2032)
  14. 5.3.3 Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Application (2021-2032)
6 Global Interleukin 2 Receptor Subunit Alpha Sales by Region
  1. 6.1 Global Interleukin 2 Receptor Subunit Alpha Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2021-2032)
  3. 6.2.1 Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2021-2026)
  4. 6.2.2 Global Interleukin 2 Receptor Subunit Alpha Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Interleukin 2 Receptor Subunit Alpha Revenue by Region
  1. 7.1 Global Interleukin 2 Receptor Subunit Alpha Revenue by Region
  2. 7.1.1 Global Interleukin 2 Receptor Subunit Alpha Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Interleukin 2 Receptor Subunit Alpha Revenue by Region (2021-2026)
  4. 7.1.3 Global Interleukin 2 Receptor Subunit Alpha Revenue by Region (2027-2032)
  5. 7.1.4 Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032)
  8. 7.2.2 North America Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032)
  11. 7.3.2 Europe Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Interleukin 2 Receptor Subunit Alpha Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie Inc.
  2. 8.1.1 AbbVie Inc. Company Information
  3. 8.1.2 AbbVie Inc. Business Overview
  4. 8.1.3 AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio
  6. 8.1.5 AbbVie Inc. Recent Developments
  7. 8.2 Philogen S.p.A.
  8. 8.2.1 Philogen S.p.A. Company Information
  9. 8.2.2 Philogen S.p.A. Business Overview
  10. 8.2.3 Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Product Portfolio
  12. 8.2.5 Philogen S.p.A. Recent Developments
  13. 8.3 Mabtech Limited
  14. 8.3.1 Mabtech Limited Company Information
  15. 8.3.2 Mabtech Limited Business Overview
  16. 8.3.3 Mabtech Limited Interleukin 2 Receptor Subunit Alpha Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mabtech Limited Interleukin 2 Receptor Subunit Alpha Product Portfolio
  18. 8.3.5 Mabtech Limited Recent Developments
  19. 8.4 APT Therapeutics, Inc.
  20. 8.4.1 APT Therapeutics, Inc. Company Information
  21. 8.4.2 APT Therapeutics, Inc. Business Overview
  22. 8.4.3 APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio
  24. 8.4.5 APT Therapeutics, Inc. Recent Developments
  25. 8.5 Alkermes Plc
  26. 8.5.1 Alkermes Plc Company Information
  27. 8.5.2 Alkermes Plc Business Overview
  28. 8.5.3 Alkermes Plc Interleukin 2 Receptor Subunit Alpha Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Alkermes Plc Interleukin 2 Receptor Subunit Alpha Product Portfolio
  30. 8.5.5 Alkermes Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Interleukin 2 Receptor Subunit Alpha Value Chain Analysis
  2. 9.1.1 Interleukin 2 Receptor Subunit Alpha Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Interleukin 2 Receptor Subunit Alpha Production Mode & Process
  6. 9.2 Interleukin 2 Receptor Subunit Alpha Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Interleukin 2 Receptor Subunit Alpha Distributors
  9. 9.2.3 Interleukin 2 Receptor Subunit Alpha Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst